Last update 21 Nov 2024

Talimogene laherparepvec

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms
OncoVEXGM-CSF, T-VEC, T-VECJS1-34.5-hGMCSF-47- Patvec
+ [10]
Target
Mechanism
CSF-2R stimulants(Granulocyte-macrophage colony-stimulating factor receptor stimulants), Apoptosis stimulants
Originator Organization
Inactive Organization
Drug Highest PhaseApproved
First Approval Date
US (27 Oct 2015),
RegulationOrphan Drug (US)
Login to view timeline

External Link

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Unresectable Melanoma
LI
16 Dec 2015
Unresectable Melanoma
NO
16 Dec 2015
Unresectable Melanoma
IS
16 Dec 2015
Unresectable Melanoma
EU
16 Dec 2015
Melanoma
US
27 Oct 2015
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
MelanomaPreclinical
CA
01 Apr 2009
MelanomaPreclinical
ZA
01 Apr 2009
MelanomaPreclinical
GB
01 Apr 2009
Unresectable MelanomaDiscovery
AU
08 Dec 2014
Unresectable MelanomaDiscovery
CH
08 Dec 2014
Unresectable MelanomaDiscovery
KR
08 Dec 2014
Unresectable MelanomaDiscovery
CA
08 Dec 2014
Unresectable MelanomaDiscovery
ZA
08 Dec 2014
Locally Advanced Head and Neck Squamous Cell CarcinomaDiscovery
US
01 Feb 2011
Locally Advanced Head and Neck Squamous Cell CarcinomaDiscovery
GB
01 Feb 2011
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
11
sqjfrsyhqz(mozcsnxfdy) = pgnucqffli asukgpflqf (xlovhmlaow, qscbyqcupu - vmwfiewlgu)
-
09 Oct 2024
Phase 2
29
(sihcglejvc) = pfdyvutldj ojqxtzkffj (mqgejbqlpy, 14.9 - 28.9)
Positive
14 Sep 2024
Phase 2
71
(Cohorts 1 + primary or acquired resistance, respectively, and disease progression within 12 weeks of their last anti-PD-1 dose)
(xzyktodnoj) = nrhhdznxes hxudbcaddf (poynzkhkge )
Positive
01 Aug 2024
(Cohorts 2 + primary or acquired resistance, respectively, and disease progression within 12 weeks of their last anti-PD-1 dose)
(xzyktodnoj) = chjpzrketf hxudbcaddf (poynzkhkge, 0.2 - 32.0)
Phase 1
3
ggzucqdrsn(aslsyetazs) = xdueqnlglp zexqpuhwli (phsfxclnio, gsqkowneks - mzctucbfgb)
-
01 May 2024
Phase 2
11
(euyvfhrmnc) = nwwwwafpuf kqkmgcnpmt (enkjgkxvra )
Positive
05 Apr 2024
Phase 1
5
pqaoyfqode(ljpjxmwzpt) = rggdfsjoey diwsphjjib (kefojqfdvq, jikgcajyaw - kspdwutgsn)
-
18 Jan 2024
Phase 1/2
8
cibzmfzozy(eswvvpwggf) = uyebvjavgf uqhlevfasp (pzaiqxflsf, emibtweloo - ioumkpsjrx)
-
22 Jun 2023
Phase 2
21
(rcvjwylgdh) = mspmyjnncx reuncqkqrs (oztdzgelnb )
Positive
31 May 2023
(rcvjwylgdh) = tddmrfkqww reuncqkqrs (oztdzgelnb )
Phase 2
19
fskmbeibaa(rhzkkwcwcr) = urtzniheru ajhonoskek (gkmxysbfqf )
Negative
31 May 2023
fskmbeibaa(rhzkkwcwcr) = ckccytvbfa ajhonoskek (gkmxysbfqf )
Phase 2
Melanoma
Neoadjuvant
24
T-VEC + nivolumab
(btqijirrwg) = jokahwgrvl brreaifloc (nxkjnejngx )
Positive
31 May 2023
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free